Skip to main content
. 2021 Mar 25:1–6. doi: 10.1017/dmp.2021.82

Table 1.

Clinical characteristics and comorbidities in 2 groups of COVID-19 patients

Demographic and Clinical Characteristics n(%) P
Improvement Death Total
(n = 140) (n = 99) (n = 239)
Age(Years) < 0.001
< 60 years 106(75.7%) 26(26.3%) 132(55.2%)
> 60 years 34(24.3%) 73(73.7%) 107(44.8%)
Sex 0.035
Male 63(45%) 59(59.6%) 122(51.0%)
Female 77(55%) 40(40.4%) 117(49.0%)
URS < 0.001
Yes 77(55%) 86(86.9%) 163(68.2%)
No 63(45%) 13(13.1%) 76(31.8%)
Dyspnea < 0.001
Yes 53(37.9%) 62(62.6%) 115(46.9%)
No 87(62.1%) 37(37.4%) 124(51.9%)
Muscle Pain 0.231
Yes 32(22.9%) 30(30.3%) 62(25.9%)
No 108(77.1%) 69(69.7%) 177(74.1%)
Headache 0.667
Yes 13(9.3%) 11(11.1%) 24(10.0%)
No 127(90.7%) 88(88.9%) 215(90.0%)
Gastrointestinal Symptoms 0.814
Yes 11(7.9%) 9(9.1%) 20(83.7%)
No 129(92.1%) 90(90.9%) 219(91.6%)
Hypertension < 0.001
Yes 18(12.9%) 46(46.5%) 64(26.8%)
No 122(87.1%) 53(53.5%) 175(73.2%)
Diabetes 0.006
Yes 11(7.9%) 20(20.2%) 31(13.0%)
No 129(92.1%) 79(79.8%) 208(87.0%)
Coronary Heart Disease < 0.001
Yes 4(2.9%) 17(17.2%) 21(8.8%)
No 136(97.1%) 82(82.8%) 218(91.2%)
Pulmonary Comorbidities 0.054
Yes 7(5%) 12(12.1%) 19(7.9%)
No 133(95%) 87(87.9%) 220(92.1%)
Cerebral Infarction 0.154
Yes 5(3.6%) 8(8.1%) 13(5.4%)
No 135(96.4%) 91(91.9%) 226(94.6%)
Temperature (°C) 0.076
< 37.3 31(22.1%) 13(13.1%) 44(18.4%)
37.4-38 27(19.3%) 12(12.1%) 39(16.3%)
38.1-39 69(49.3%) 64(64.6%) 133(55.6%)
> 39 13(9.3%) 10(10.1%) 23(9.6%)
Time to Admission (days) < 0.001
> 6 61(43.6%) 68(68.7%) 129 (54.0%)
≤ 6 79(56.4%) 31(31.3%) 110 (46.0%)
Hospital Days (days) < 0.001
> 7 117(83.6%) 26(26.3%) 143(59.8%)
≤ 7 23(16.4%) 73(73.7%) 96(40.2%)
Clinical Type < 0.001
Light type 8(5.6%) 0(0.0%) 8(3.3%)
Common type 127(91.4%) 6(6.1%) 133(55.6%)
Severe type 9(6.5%) 8(8.1%) 17(7.1%)
critical type 2(1.4%) 85(85.8%) 87(36.4%)

Notes: Data described by frequency; URS = upper respiratory symptoms.